87% Survival – New Combined Therapy Greatly Improves Prostate Cancer Survival

United States News News

87% Survival – New Combined Therapy Greatly Improves Prostate Cancer Survival
United States Latest News,United States Headlines
  • 📰 SciTechDaily1
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 68%

A Cedars-Sinai cancer study indicates improved survival following a combination of hormone therapy and pelvic lymph node treatment A combination of androgen deprivation therapy—a common hormone injection—and pelvic lymph node radiotherapy prevented prostate cancer from therapy in nearly 90% of clin

The combination therapy patient group underwent pelvic lymph node radiation and androgen deprivation treatment, as well as salvage prostate bed radiation. Over 87 percent of these patients had five-year freedom from cancer progression.

The research also demonstrates that individuals with prostate cancer who did not get pelvic lymph node radiotherapy or androgen restriction treatment had a five-year survival rate of 70%. Salvage prostate bed radiotherapy was administered to Group 1; this kind of radiation is often directed towards the prostate’s former location before it was surgically removed. The median five-year survival rate for these individuals was 71%.

“The combined treatment approach proved to be the most beneficial approach,” said Sandler, also the Ronald H. Bloom Family Chair in Cancer Therapeutics and professor of Radiation Oncology at Cedars-Sinai.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

SciTechDaily1 /  🏆 84. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Missing vulnerable 87-year-old man foundMissing vulnerable 87-year-old man foundTucson police is in search of a missing vulnerable 87-year-old man. The man is identified as Jose Yescas.
Read more »

Missing vulnerable 87-year-old manMissing vulnerable 87-year-old manTucson police is in search of a missing vulnerable 87-year-old man. The man is identified as Jose Yescas.
Read more »

Where The Crawdads Sing Begins and Ends With SurvivalWhere The Crawdads Sing Begins and Ends With SurvivalThe film, based off the bestselling novel, offers a meditation on abuse and trauma
Read more »

How climate change is now threatening the survival of fire-adaptive sequoia treesHow climate change is now threatening the survival of fire-adaptive sequoia treesNestled on the Western slope of the Sierra Nevada mountain range live isolated patches of some of the world's oldest and most magnificent species of tree.
Read more »

My Last Visit with John BennetMy Last Visit with John Bennet.MaryNorrisTNY remembers her final visits with the former New Yorker editor John Bennet, who died earlier this month.
Read more »

Amazon Involved With New Cancer Vaccine Clinical TrialAmazon Involved With New Cancer Vaccine Clinical TrialAmazon is working with the Fred Hutchinson Cancer Research Center to develop cancer vaccines in a new clinical trial.
Read more »



Render Time: 2025-02-22 22:25:00